Capricor Therapeutics Inc CAPR
$6.65
+57.96%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (5 Buy · 3 Hold · 0 Sell)
- Average Price Target
- $35.00
- Implied Upside
- +426.3%
- Price Target Range
- $2.00 – $63.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-14 | Cantor FitzgeraldKristen Kluska |
Upgrades | Neutral → Overweight | $4 → $28 |
| 2026-07-31 | Jones TradingCatherine Novack |
Downgrades | Buy → Hold | — |
| 2026-07-30 | Piper SandlerEdward Tenthoff |
Downgrades | Overweight → Neutral | $58 → $2 |
| 2026-07-30 | Cantor FitzgeraldKristen Kluska |
Downgrades | Overweight → Neutral | $62 → $4 |
| 2026-07-30 | HC Wainwright & Co.Joseph Pantginis |
Downgrades | Buy → Neutral | — |
| 2026-05-13 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $60 |
| 2026-03-13 | B. Riley SecuritiesMadison El-Saadi |
Maintains | Buy | $50 → $63 |
| 2026-03-13 | Piper SandlerEdward Tenthoff |
Reiterates | Overweight | $45 → $58 |
| 2026-03-13 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $60 |
| 2026-03-10 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $60 |
| 2025-12-15 | B. Riley SecuritiesMadison El-Saadi |
Reiterates | Buy | $21 → $50 |
| 2025-12-10 | Piper SandlerEdward Tenthoff |
Reiterates | Overweight | $20 → $45 |
| 2025-12-08 | OppenheimerLeland Gershell |
Maintains | Outperform | $22 → $54 |
| 2025-12-04 | Maxim GroupJason McCarthy |
Maintains | Buy | $25 → $50 |
| 2025-12-03 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $24 → $60 |
| 2025-11-12 | Roth CapitalBoobalan Pachaiyappan |
Maintains | Buy | $12 → $13 |
| 2025-09-25 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $24 |
| 2025-09-11 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $24 |
| 2025-07-14 | Roth CapitalBoobalan Pachaiyappan |
Maintains | Buy | $31 → $12 |
| 2025-07-11 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $77 → $24 |
| 2025-06-26 | B. Riley SecuritiesMadison El-Saadi |
Initiates coverage on | Buy | $21 |
| 2025-06-25 | Jones TradingCatherine Novack |
Maintains | Buy | $40 → $29 |
| 2025-06-24 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $77 |
| 2025-06-23 | OppenheimerLeland Gershell |
Maintains | Outperform | $43 → $22 |
| 2025-06-17 | Roth CapitalBoobalan Pachaiyappan |
Reiterates | Buy | $31 |
| 2025-06-13 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $77 |
| 2025-05-14 | Cantor FitzgeraldKristen Kluska |
Reiterates | Overweight | $30 |
| 2025-03-20 | Cantor FitzgeraldKristen Kluska |
Reiterates | Overweight | $30 |
| 2025-03-20 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $77 |
| 2025-03-17 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $77 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $6.65
- Market Cap
- $242.65 million
- 52-Week Range
- $2.96 – $40.37
- Average Volume
- 7.35 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.